(1)
Study of the Efficacy and Safety of Stereotactic Radiation Therapy in Combination With Trastuzumab Emtansine Immunoconjugate in Patients With HER-2-Positive Oligometastatic Breast Cancer. Interim Results. Вопр. онкол. 2025, 71 (3), OF-2347. https://doi.org/10.37469/0507-3758-2025-71-3-OF-2347.